Literature DB >> 978450

GLC determination of cyclobenzaprine in plasma and urine.

H B Hucker, S C Stauffer.   

Abstract

A GLC determination of cyclobenzaprine in human plasma and urine is described. After extraction from alkalinized samples with heptane-isopentyl alcohol (97:3), the drug and internal standard were back-extracted into 0.1 N HCl and then reextracted into ether. Use of a lower homolog of the drug as an internal standard was effective in reducing variability. Drug concentrations as low as 25 ng/ml could be assayed with high precision. Plasma levels in humans given 40 mg po or iv ranged from 5 to 51 ng/ml; little unchanged cyclobenzaprine was present in the urine. The N-desmethyl analog of the drug was detected as a metabolite in urine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978450     DOI: 10.1002/jps.2600650832

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets.

Authors:  Tatiane Maria de Lima Souza Brioschi; Simone Grigoleto Schramm; Eunice Kazue Kano; Eunice Emiko Mori Koono; Ting Hui Ching; Cristina Helena Dos Reis Serra; Valentina Porta
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411

2.  Fabrication of an (α-Mn2O3:Co)-decorated CNT highly sensitive screen printed electrode for the optimization and electrochemical determination of cyclobenzaprine hydrochloride using response surface methodology.

Authors:  Ahmed M Abdel-Raoof; Ayman O E Osman; Ebrahim A El-Desouky; Ashraf Abdel-Fattah; Rady F Abdul-Kareem; Elsayed Elgazzar
Journal:  RSC Adv       Date:  2020-07-01       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.